Glivec became Gleevec, Cidecin became Cubicin, and Antegren became Tysabri (those are for cancer, bacterial infection, and multiple sclerosis, respectively.) But changes in generic name seem less common.

FORBES: Why Pfizer's Biggest Experimental Drug Got A Name Change